カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

ハイブリッド式バイオ人工靱帯のグローバル市場2023：前十字靱帯（ACL）、後十字靱帯（PCL）、内側十字靱帯（MCL）

■ 英語タイトル：Global Hybrid bio-artificial Ligament Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23AG10757）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23AG10757
■ 発行日：2023年8月
■ 調査対象地域：グローバル
■ 産業分野：医療機器＆消耗品
■ ページ数：106
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ハイブリッド式バイオ人工靱帯のグローバル市場2023：前十字靱帯（ACL）、後十字靱帯（PCL）、内側十字靱帯（MCL）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Global Info Research社の最新の調査によると、ハイブリッド式バイオ人工靱帯のグローバル市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
本調査レポートは、世界のハイブリッド式バイオ人工靱帯市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本資料の主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- ハイブリッド式バイオ人工靱帯の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

ハイブリッド式バイオ人工靱帯市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・前十字靱帯（ACL）、後十字靱帯（PCL）、内側十字靱帯（MCL）

用途別セグメント
・膝の怪我、肩の怪我、足&足首の怪我、その他

主要な市場プレーヤー
・Movmedix、Orthomed、Corin Group、Neoligaments、Biorez、FH ORTHO、Mathys、Teijin、Exactech、Cousin Biotech、CoreTissue BioEngineering、Shanghai Pine & Power Biotech、Shanghai Ligatech Bioscience

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ハイブリッド式バイオ人工靱帯製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なハイブリッド式バイオ人工靱帯メーカーの企業概要、2019年～2022年までのハイブリッド式バイオ人工靱帯の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なハイブリッド式バイオ人工靱帯メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別ハイブリッド式バイオ人工靱帯の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのハイブリッド式バイオ人工靱帯の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのハイブリッド式バイオ人工靱帯市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびハイブリッド式バイオ人工靱帯の産業チェーンを掲載しています。
・第14、15章では、ハイブリッド式バイオ人工靱帯の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– ハイブリッド式バイオ人工靱帯の概要
– 種類別分析（2018年vs2022年vs2029年）：前十字靱帯（ACL）、後十字靱帯（PCL）、内側十字靱帯（MCL）
– 用途別分析（2018年vs2022年vs2029年）：膝の怪我、肩の怪我、足&足首の怪我、その他
– 世界のハイブリッド式バイオ人工靱帯市場規模・予測
– 世界のハイブリッド式バイオ人工靱帯生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Movmedix、Orthomed、Corin Group、Neoligaments、Biorez、FH ORTHO、Mathys、Teijin、Exactech、Cousin Biotech、CoreTissue BioEngineering、Shanghai Pine & Power Biotech、Shanghai Ligatech Bioscience
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：前十字靱帯（ACL）、後十字靱帯（PCL）、内側十字靱帯（MCL）
・用途別分析2018年-2029年：膝の怪我、肩の怪我、足&足首の怪我、その他
・ハイブリッド式バイオ人工靱帯の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ハイブリッド式バイオ人工靱帯のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ハイブリッド式バイオ人工靱帯のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ハイブリッド式バイオ人工靱帯の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ハイブリッド式バイオ人工靱帯の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Hybrid bio-artificial Ligament
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Hybrid bio-artificial Ligament Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Anterior Cruciate Ligament (ACL)
1.3.3 Posterior Cruciate Ligament (PCL)
1.3.4 Medial Cruciate Ligament (MCL)
1.4 Market Analysis by Application
1.4.1 Overview: Global Hybrid bio-artificial Ligament Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Knee Injuries
1.4.3 Shoulder Injuries
1.4.4 Foot and Ankle Injuries
1.4.5 Other
1.5 Global Hybrid bio-artificial Ligament Market Size & Forecast
1.5.1 Global Hybrid bio-artificial Ligament Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Hybrid bio-artificial Ligament Sales Quantity (2018-2029)
1.5.3 Global Hybrid bio-artificial Ligament Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Movmedix
2.1.1 Movmedix Details
2.1.2 Movmedix Major Business
2.1.3 Movmedix Hybrid bio-artificial Ligament Product and Services
2.1.4 Movmedix Hybrid bio-artificial Ligament Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Movmedix Recent Developments/Updates
2.2 Orthomed
2.2.1 Orthomed Details
2.2.2 Orthomed Major Business
2.2.3 Orthomed Hybrid bio-artificial Ligament Product and Services
2.2.4 Orthomed Hybrid bio-artificial Ligament Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Orthomed Recent Developments/Updates
2.3 Corin Group
2.3.1 Corin Group Details
2.3.2 Corin Group Major Business
2.3.3 Corin Group Hybrid bio-artificial Ligament Product and Services
2.3.4 Corin Group Hybrid bio-artificial Ligament Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Corin Group Recent Developments/Updates
2.4 Neoligaments
2.4.1 Neoligaments Details
2.4.2 Neoligaments Major Business
2.4.3 Neoligaments Hybrid bio-artificial Ligament Product and Services
2.4.4 Neoligaments Hybrid bio-artificial Ligament Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Neoligaments Recent Developments/Updates
2.5 Biorez
2.5.1 Biorez Details
2.5.2 Biorez Major Business
2.5.3 Biorez Hybrid bio-artificial Ligament Product and Services
2.5.4 Biorez Hybrid bio-artificial Ligament Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Biorez Recent Developments/Updates
2.6 FH ORTHO
2.6.1 FH ORTHO Details
2.6.2 FH ORTHO Major Business
2.6.3 FH ORTHO Hybrid bio-artificial Ligament Product and Services
2.6.4 FH ORTHO Hybrid bio-artificial Ligament Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 FH ORTHO Recent Developments/Updates
2.7 Mathys
2.7.1 Mathys Details
2.7.2 Mathys Major Business
2.7.3 Mathys Hybrid bio-artificial Ligament Product and Services
2.7.4 Mathys Hybrid bio-artificial Ligament Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Mathys Recent Developments/Updates
2.8 Teijin
2.8.1 Teijin Details
2.8.2 Teijin Major Business
2.8.3 Teijin Hybrid bio-artificial Ligament Product and Services
2.8.4 Teijin Hybrid bio-artificial Ligament Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Teijin Recent Developments/Updates
2.9 Exactech
2.9.1 Exactech Details
2.9.2 Exactech Major Business
2.9.3 Exactech Hybrid bio-artificial Ligament Product and Services
2.9.4 Exactech Hybrid bio-artificial Ligament Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Exactech Recent Developments/Updates
2.10 Cousin Biotech
2.10.1 Cousin Biotech Details
2.10.2 Cousin Biotech Major Business
2.10.3 Cousin Biotech Hybrid bio-artificial Ligament Product and Services
2.10.4 Cousin Biotech Hybrid bio-artificial Ligament Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Cousin Biotech Recent Developments/Updates
2.11 CoreTissue BioEngineering
2.11.1 CoreTissue BioEngineering Details
2.11.2 CoreTissue BioEngineering Major Business
2.11.3 CoreTissue BioEngineering Hybrid bio-artificial Ligament Product and Services
2.11.4 CoreTissue BioEngineering Hybrid bio-artificial Ligament Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 CoreTissue BioEngineering Recent Developments/Updates
2.12 Shanghai Pine & Power Biotech
2.12.1 Shanghai Pine & Power Biotech Details
2.12.2 Shanghai Pine & Power Biotech Major Business
2.12.3 Shanghai Pine & Power Biotech Hybrid bio-artificial Ligament Product and Services
2.12.4 Shanghai Pine & Power Biotech Hybrid bio-artificial Ligament Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Shanghai Pine & Power Biotech Recent Developments/Updates
2.13 Shanghai Ligatech Bioscience
2.13.1 Shanghai Ligatech Bioscience Details
2.13.2 Shanghai Ligatech Bioscience Major Business
2.13.3 Shanghai Ligatech Bioscience Hybrid bio-artificial Ligament Product and Services
2.13.4 Shanghai Ligatech Bioscience Hybrid bio-artificial Ligament Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Shanghai Ligatech Bioscience Recent Developments/Updates
3 Competitive Environment: Hybrid bio-artificial Ligament by Manufacturer
3.1 Global Hybrid bio-artificial Ligament Sales Quantity by Manufacturer (2018-2023)
3.2 Global Hybrid bio-artificial Ligament Revenue by Manufacturer (2018-2023)
3.3 Global Hybrid bio-artificial Ligament Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Hybrid bio-artificial Ligament by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Hybrid bio-artificial Ligament Manufacturer Market Share in 2022
3.4.2 Top 6 Hybrid bio-artificial Ligament Manufacturer Market Share in 2022
3.5 Hybrid bio-artificial Ligament Market: Overall Company Footprint Analysis
3.5.1 Hybrid bio-artificial Ligament Market: Region Footprint
3.5.2 Hybrid bio-artificial Ligament Market: Company Product Type Footprint
3.5.3 Hybrid bio-artificial Ligament Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Hybrid bio-artificial Ligament Market Size by Region
4.1.1 Global Hybrid bio-artificial Ligament Sales Quantity by Region (2018-2029)
4.1.2 Global Hybrid bio-artificial Ligament Consumption Value by Region (2018-2029)
4.1.3 Global Hybrid bio-artificial Ligament Average Price by Region (2018-2029)
4.2 North America Hybrid bio-artificial Ligament Consumption Value (2018-2029)
4.3 Europe Hybrid bio-artificial Ligament Consumption Value (2018-2029)
4.4 Asia-Pacific Hybrid bio-artificial Ligament Consumption Value (2018-2029)
4.5 South America Hybrid bio-artificial Ligament Consumption Value (2018-2029)
4.6 Middle East and Africa Hybrid bio-artificial Ligament Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Hybrid bio-artificial Ligament Sales Quantity by Type (2018-2029)
5.2 Global Hybrid bio-artificial Ligament Consumption Value by Type (2018-2029)
5.3 Global Hybrid bio-artificial Ligament Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Hybrid bio-artificial Ligament Sales Quantity by Application (2018-2029)
6.2 Global Hybrid bio-artificial Ligament Consumption Value by Application (2018-2029)
6.3 Global Hybrid bio-artificial Ligament Average Price by Application (2018-2029)
7 North America
7.1 North America Hybrid bio-artificial Ligament Sales Quantity by Type (2018-2029)
7.2 North America Hybrid bio-artificial Ligament Sales Quantity by Application (2018-2029)
7.3 North America Hybrid bio-artificial Ligament Market Size by Country
7.3.1 North America Hybrid bio-artificial Ligament Sales Quantity by Country (2018-2029)
7.3.2 North America Hybrid bio-artificial Ligament Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Hybrid bio-artificial Ligament Sales Quantity by Type (2018-2029)
8.2 Europe Hybrid bio-artificial Ligament Sales Quantity by Application (2018-2029)
8.3 Europe Hybrid bio-artificial Ligament Market Size by Country
8.3.1 Europe Hybrid bio-artificial Ligament Sales Quantity by Country (2018-2029)
8.3.2 Europe Hybrid bio-artificial Ligament Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Hybrid bio-artificial Ligament Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Hybrid bio-artificial Ligament Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Hybrid bio-artificial Ligament Market Size by Region
9.3.1 Asia-Pacific Hybrid bio-artificial Ligament Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Hybrid bio-artificial Ligament Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Hybrid bio-artificial Ligament Sales Quantity by Type (2018-2029)
10.2 South America Hybrid bio-artificial Ligament Sales Quantity by Application (2018-2029)
10.3 South America Hybrid bio-artificial Ligament Market Size by Country
10.3.1 South America Hybrid bio-artificial Ligament Sales Quantity by Country (2018-2029)
10.3.2 South America Hybrid bio-artificial Ligament Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Hybrid bio-artificial Ligament Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Hybrid bio-artificial Ligament Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Hybrid bio-artificial Ligament Market Size by Country
11.3.1 Middle East & Africa Hybrid bio-artificial Ligament Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Hybrid bio-artificial Ligament Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Hybrid bio-artificial Ligament Market Drivers
12.2 Hybrid bio-artificial Ligament Market Restraints
12.3 Hybrid bio-artificial Ligament Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Hybrid bio-artificial Ligament and Key Manufacturers
13.2 Manufacturing Costs Percentage of Hybrid bio-artificial Ligament
13.3 Hybrid bio-artificial Ligament Production Process
13.4 Hybrid bio-artificial Ligament Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Hybrid bio-artificial Ligament Typical Distributors
14.3 Hybrid bio-artificial Ligament Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Hybrid bio-artificial Ligament Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Hybrid bio-artificial Ligament Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Movmedix Basic Information, Manufacturing Base and Competitors
Table 4. Movmedix Major Business
Table 5. Movmedix Hybrid bio-artificial Ligament Product and Services
Table 6. Movmedix Hybrid bio-artificial Ligament Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Movmedix Recent Developments/Updates
Table 8. Orthomed Basic Information, Manufacturing Base and Competitors
Table 9. Orthomed Major Business
Table 10. Orthomed Hybrid bio-artificial Ligament Product and Services
Table 11. Orthomed Hybrid bio-artificial Ligament Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Orthomed Recent Developments/Updates
Table 13. Corin Group Basic Information, Manufacturing Base and Competitors
Table 14. Corin Group Major Business
Table 15. Corin Group Hybrid bio-artificial Ligament Product and Services
Table 16. Corin Group Hybrid bio-artificial Ligament Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Corin Group Recent Developments/Updates
Table 18. Neoligaments Basic Information, Manufacturing Base and Competitors
Table 19. Neoligaments Major Business
Table 20. Neoligaments Hybrid bio-artificial Ligament Product and Services
Table 21. Neoligaments Hybrid bio-artificial Ligament Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Neoligaments Recent Developments/Updates
Table 23. Biorez Basic Information, Manufacturing Base and Competitors
Table 24. Biorez Major Business
Table 25. Biorez Hybrid bio-artificial Ligament Product and Services
Table 26. Biorez Hybrid bio-artificial Ligament Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Biorez Recent Developments/Updates
Table 28. FH ORTHO Basic Information, Manufacturing Base and Competitors
Table 29. FH ORTHO Major Business
Table 30. FH ORTHO Hybrid bio-artificial Ligament Product and Services
Table 31. FH ORTHO Hybrid bio-artificial Ligament Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. FH ORTHO Recent Developments/Updates
Table 33. Mathys Basic Information, Manufacturing Base and Competitors
Table 34. Mathys Major Business
Table 35. Mathys Hybrid bio-artificial Ligament Product and Services
Table 36. Mathys Hybrid bio-artificial Ligament Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Mathys Recent Developments/Updates
Table 38. Teijin Basic Information, Manufacturing Base and Competitors
Table 39. Teijin Major Business
Table 40. Teijin Hybrid bio-artificial Ligament Product and Services
Table 41. Teijin Hybrid bio-artificial Ligament Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Teijin Recent Developments/Updates
Table 43. Exactech Basic Information, Manufacturing Base and Competitors
Table 44. Exactech Major Business
Table 45. Exactech Hybrid bio-artificial Ligament Product and Services
Table 46. Exactech Hybrid bio-artificial Ligament Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Exactech Recent Developments/Updates
Table 48. Cousin Biotech Basic Information, Manufacturing Base and Competitors
Table 49. Cousin Biotech Major Business
Table 50. Cousin Biotech Hybrid bio-artificial Ligament Product and Services
Table 51. Cousin Biotech Hybrid bio-artificial Ligament Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Cousin Biotech Recent Developments/Updates
Table 53. CoreTissue BioEngineering Basic Information, Manufacturing Base and Competitors
Table 54. CoreTissue BioEngineering Major Business
Table 55. CoreTissue BioEngineering Hybrid bio-artificial Ligament Product and Services
Table 56. CoreTissue BioEngineering Hybrid bio-artificial Ligament Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. CoreTissue BioEngineering Recent Developments/Updates
Table 58. Shanghai Pine & Power Biotech Basic Information, Manufacturing Base and Competitors
Table 59. Shanghai Pine & Power Biotech Major Business
Table 60. Shanghai Pine & Power Biotech Hybrid bio-artificial Ligament Product and Services
Table 61. Shanghai Pine & Power Biotech Hybrid bio-artificial Ligament Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Shanghai Pine & Power Biotech Recent Developments/Updates
Table 63. Shanghai Ligatech Bioscience Basic Information, Manufacturing Base and Competitors
Table 64. Shanghai Ligatech Bioscience Major Business
Table 65. Shanghai Ligatech Bioscience Hybrid bio-artificial Ligament Product and Services
Table 66. Shanghai Ligatech Bioscience Hybrid bio-artificial Ligament Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Shanghai Ligatech Bioscience Recent Developments/Updates
Table 68. Global Hybrid bio-artificial Ligament Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 69. Global Hybrid bio-artificial Ligament Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Hybrid bio-artificial Ligament Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 71. Market Position of Manufacturers in Hybrid bio-artificial Ligament, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Hybrid bio-artificial Ligament Production Site of Key Manufacturer
Table 73. Hybrid bio-artificial Ligament Market: Company Product Type Footprint
Table 74. Hybrid bio-artificial Ligament Market: Company Product Application Footprint
Table 75. Hybrid bio-artificial Ligament New Market Entrants and Barriers to Market Entry
Table 76. Hybrid bio-artificial Ligament Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Hybrid bio-artificial Ligament Sales Quantity by Region (2018-2023) & (K Units)
Table 78. Global Hybrid bio-artificial Ligament Sales Quantity by Region (2024-2029) & (K Units)
Table 79. Global Hybrid bio-artificial Ligament Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Hybrid bio-artificial Ligament Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Hybrid bio-artificial Ligament Average Price by Region (2018-2023) & (US$/Unit)
Table 82. Global Hybrid bio-artificial Ligament Average Price by Region (2024-2029) & (US$/Unit)
Table 83. Global Hybrid bio-artificial Ligament Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Global Hybrid bio-artificial Ligament Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Global Hybrid bio-artificial Ligament Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Hybrid bio-artificial Ligament Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Hybrid bio-artificial Ligament Average Price by Type (2018-2023) & (US$/Unit)
Table 88. Global Hybrid bio-artificial Ligament Average Price by Type (2024-2029) & (US$/Unit)
Table 89. Global Hybrid bio-artificial Ligament Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Global Hybrid bio-artificial Ligament Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Global Hybrid bio-artificial Ligament Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Hybrid bio-artificial Ligament Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Hybrid bio-artificial Ligament Average Price by Application (2018-2023) & (US$/Unit)
Table 94. Global Hybrid bio-artificial Ligament Average Price by Application (2024-2029) & (US$/Unit)
Table 95. North America Hybrid bio-artificial Ligament Sales Quantity by Type (2018-2023) & (K Units)
Table 96. North America Hybrid bio-artificial Ligament Sales Quantity by Type (2024-2029) & (K Units)
Table 97. North America Hybrid bio-artificial Ligament Sales Quantity by Application (2018-2023) & (K Units)
Table 98. North America Hybrid bio-artificial Ligament Sales Quantity by Application (2024-2029) & (K Units)
Table 99. North America Hybrid bio-artificial Ligament Sales Quantity by Country (2018-2023) & (K Units)
Table 100. North America Hybrid bio-artificial Ligament Sales Quantity by Country (2024-2029) & (K Units)
Table 101. North America Hybrid bio-artificial Ligament Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Hybrid bio-artificial Ligament Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Hybrid bio-artificial Ligament Sales Quantity by Type (2018-2023) & (K Units)
Table 104. Europe Hybrid bio-artificial Ligament Sales Quantity by Type (2024-2029) & (K Units)
Table 105. Europe Hybrid bio-artificial Ligament Sales Quantity by Application (2018-2023) & (K Units)
Table 106. Europe Hybrid bio-artificial Ligament Sales Quantity by Application (2024-2029) & (K Units)
Table 107. Europe Hybrid bio-artificial Ligament Sales Quantity by Country (2018-2023) & (K Units)
Table 108. Europe Hybrid bio-artificial Ligament Sales Quantity by Country (2024-2029) & (K Units)
Table 109. Europe Hybrid bio-artificial Ligament Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Hybrid bio-artificial Ligament Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Hybrid bio-artificial Ligament Sales Quantity by Type (2018-2023) & (K Units)
Table 112. Asia-Pacific Hybrid bio-artificial Ligament Sales Quantity by Type (2024-2029) & (K Units)
Table 113. Asia-Pacific Hybrid bio-artificial Ligament Sales Quantity by Application (2018-2023) & (K Units)
Table 114. Asia-Pacific Hybrid bio-artificial Ligament Sales Quantity by Application (2024-2029) & (K Units)
Table 115. Asia-Pacific Hybrid bio-artificial Ligament Sales Quantity by Region (2018-2023) & (K Units)
Table 116. Asia-Pacific Hybrid bio-artificial Ligament Sales Quantity by Region (2024-2029) & (K Units)
Table 117. Asia-Pacific Hybrid bio-artificial Ligament Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Hybrid bio-artificial Ligament Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Hybrid bio-artificial Ligament Sales Quantity by Type (2018-2023) & (K Units)
Table 120. South America Hybrid bio-artificial Ligament Sales Quantity by Type (2024-2029) & (K Units)
Table 121. South America Hybrid bio-artificial Ligament Sales Quantity by Application (2018-2023) & (K Units)
Table 122. South America Hybrid bio-artificial Ligament Sales Quantity by Application (2024-2029) & (K Units)
Table 123. South America Hybrid bio-artificial Ligament Sales Quantity by Country (2018-2023) & (K Units)
Table 124. South America Hybrid bio-artificial Ligament Sales Quantity by Country (2024-2029) & (K Units)
Table 125. South America Hybrid bio-artificial Ligament Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Hybrid bio-artificial Ligament Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Hybrid bio-artificial Ligament Sales Quantity by Type (2018-2023) & (K Units)
Table 128. Middle East & Africa Hybrid bio-artificial Ligament Sales Quantity by Type (2024-2029) & (K Units)
Table 129. Middle East & Africa Hybrid bio-artificial Ligament Sales Quantity by Application (2018-2023) & (K Units)
Table 130. Middle East & Africa Hybrid bio-artificial Ligament Sales Quantity by Application (2024-2029) & (K Units)
Table 131. Middle East & Africa Hybrid bio-artificial Ligament Sales Quantity by Region (2018-2023) & (K Units)
Table 132. Middle East & Africa Hybrid bio-artificial Ligament Sales Quantity by Region (2024-2029) & (K Units)
Table 133. Middle East & Africa Hybrid bio-artificial Ligament Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Hybrid bio-artificial Ligament Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Hybrid bio-artificial Ligament Raw Material
Table 136. Key Manufacturers of Hybrid bio-artificial Ligament Raw Materials
Table 137. Hybrid bio-artificial Ligament Typical Distributors
Table 138. Hybrid bio-artificial Ligament Typical Customers
List of Figures
Figure 1. Hybrid bio-artificial Ligament Picture
Figure 2. Global Hybrid bio-artificial Ligament Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Hybrid bio-artificial Ligament Consumption Value Market Share by Type in 2022
Figure 4. Anterior Cruciate Ligament (ACL) Examples
Figure 5. Posterior Cruciate Ligament (PCL) Examples
Figure 6. Medial Cruciate Ligament (MCL) Examples
Figure 7. Global Hybrid bio-artificial Ligament Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Hybrid bio-artificial Ligament Consumption Value Market Share by Application in 2022
Figure 9. Knee Injuries Examples
Figure 10. Shoulder Injuries Examples
Figure 11. Foot and Ankle Injuries Examples
Figure 12. Other Examples
Figure 13. Global Hybrid bio-artificial Ligament Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Hybrid bio-artificial Ligament Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Hybrid bio-artificial Ligament Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Hybrid bio-artificial Ligament Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Hybrid bio-artificial Ligament Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Hybrid bio-artificial Ligament Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Hybrid bio-artificial Ligament by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Hybrid bio-artificial Ligament Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Hybrid bio-artificial Ligament Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Hybrid bio-artificial Ligament Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Hybrid bio-artificial Ligament Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Hybrid bio-artificial Ligament Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Hybrid bio-artificial Ligament Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Hybrid bio-artificial Ligament Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Hybrid bio-artificial Ligament Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Hybrid bio-artificial Ligament Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Hybrid bio-artificial Ligament Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Hybrid bio-artificial Ligament Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Hybrid bio-artificial Ligament Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Hybrid bio-artificial Ligament Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Hybrid bio-artificial Ligament Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Hybrid bio-artificial Ligament Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Hybrid bio-artificial Ligament Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Hybrid bio-artificial Ligament Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Hybrid bio-artificial Ligament Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Hybrid bio-artificial Ligament Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Hybrid bio-artificial Ligament Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Hybrid bio-artificial Ligament Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Hybrid bio-artificial Ligament Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Hybrid bio-artificial Ligament Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Hybrid bio-artificial Ligament Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Hybrid bio-artificial Ligament Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Hybrid bio-artificial Ligament Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Hybrid bio-artificial Ligament Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Hybrid bio-artificial Ligament Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Hybrid bio-artificial Ligament Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Hybrid bio-artificial Ligament Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Hybrid bio-artificial Ligament Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Hybrid bio-artificial Ligament Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Hybrid bio-artificial Ligament Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Hybrid bio-artificial Ligament Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Hybrid bio-artificial Ligament Consumption Value Market Share by Region (2018-2029)
Figure 55. China Hybrid bio-artificial Ligament Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Hybrid bio-artificial Ligament Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Hybrid bio-artificial Ligament Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Hybrid bio-artificial Ligament Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Hybrid bio-artificial Ligament Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Hybrid bio-artificial Ligament Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Hybrid bio-artificial Ligament Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Hybrid bio-artificial Ligament Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Hybrid bio-artificial Ligament Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Hybrid bio-artificial Ligament Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Hybrid bio-artificial Ligament Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Hybrid bio-artificial Ligament Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Hybrid bio-artificial Ligament Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Hybrid bio-artificial Ligament Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Hybrid bio-artificial Ligament Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Hybrid bio-artificial Ligament Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Hybrid bio-artificial Ligament Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Hybrid bio-artificial Ligament Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Hybrid bio-artificial Ligament Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Hybrid bio-artificial Ligament Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Hybrid bio-artificial Ligament Market Drivers
Figure 76. Hybrid bio-artificial Ligament Market Restraints
Figure 77. Hybrid bio-artificial Ligament Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Hybrid bio-artificial Ligament in 2022
Figure 80. Manufacturing Process Analysis of Hybrid bio-artificial Ligament
Figure 81. Hybrid bio-artificial Ligament Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 人工合成靱帯のグローバル市場2023：前十字靱帯（ACL）、後十字靱帯（PCL）、内側十字靱帯（MCL）
  • ハイブリッドバイオ人工靱帯の世界市場2023-2029：前十字靱帯（ACL）、後十字靱帯（PCL）、内側十字靱帯（MCL）
  • 十字靭帯修復処置のグローバル市場（～2027）：前十字靱帯（ACL）修復、後十字靱帯（PCL）修復
  • 二重靱帯ヘルニアのグローバル市場2023：小型、中型、大型、特大型
  • 十字靭帯干渉ねじのグローバル市場2023：吸収性、非吸収性
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23AG10757 )"ハイブリッド式バイオ人工靱帯のグローバル市場2023：前十字靱帯（ACL）、後十字靱帯（PCL）、内側十字靱帯（MCL）" (英文：Global Hybrid bio-artificial Ligament Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。